Neuphoria Therapeutics Growth Metrics (2023-2025) | NEUP

Growth Metrics Jun2023 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Growth Ratios
Assets Growth (1y) -38.56%19.32%101.44%
Assets Growth (3y) 242.43%-28.36%-15.14%
Assets Growth (5y) 109.06%
Assets (QoQ) -20.72%69.05%-6.91%-4.36%33.84%
Cash & Equivalents Growth (1y) -49.26%68.88%410.30%
Cash & Equivalents Growth (3y) 59.60%-47.13%-16.08%
Cash & Equivalents Growth (5y) 36.49%
Cash & Equivalents (QoQ) -46.25%292.32%-16.63%-3.95%62.42%
Cash from Operations Growth (1y) 14.28%-91.49%
Cash from Operations (QoQ) 24.25%442.19%-131.33%-5.56%-69.22%
EBITDA Margin (QoQ) -0.04M5.88M
EBIT Growth (1y) -58.44%-9.65%
EBIT Margin (QoQ) 0.06M4.39M
EBIT (QoQ) -3.81%423.40%-148.72%3.13%28.16%
EBT Growth (1y) -961.00%194.70%
EBT Margin (QoQ) 0.04M11.62M
EBT (QoQ) -106.17%678.80%-237.95%35.55%118.40%
Enterprise Value Growth (1y) 49.26%-69.85%-403.56%
Enterprise Value Growth (3y) -59.60%46.83%15.92%
Enterprise Value Growth (5y) -36.64%
Enterprise Value (QoQ) 45.33%-285.75%16.17%3.92%-62.08%
EPS (Basic) Growth (1y) -611.29%133.33%
EPS (Basic) (QoQ) -98.39%632.52%-242.59%52.78%109.30%
EPS (Weighted Average and Diluted) Growth (1y) -611.29%56.98%
EPS (Weighted Average and Diluted) (QoQ) -188.71%465.92%-242.59%52.78%82.54%
FCF Margin (QoQ) 0.06M2.71M
Free Cash Flow Growth (1y) 14.28%-91.49%
Free Cash Flow (QoQ) 24.25%442.19%-131.33%-5.56%-69.22%
Net Cash Flow Growth (1y) 88.28%337.25%
Net Cash Flow (QoQ) 25.55%464.70%-122.88%81.13%1,606.59%
Net Income Growth (1y) -1,130.95%193.46%
Net Income (QoQ) -138.59%686.53%-234.58%34.64%118.11%
Net Income towards Common Stockholders Growth (1y) -1,130.95%193.46%
Net Income towards Common Stockholders (QoQ) -138.59%686.53%-234.58%34.64%118.11%
Net Margin (QoQ) 0.04M11.42M
Operating Income Growth (1y) -58.44%-9.65%
Operating Income (QoQ) -3.81%423.40%-148.72%3.13%28.16%
Operating Margin (QoQ) 0.06M4.39M
Profit After Tax Growth (1y) -1,130.95%195.92%
Profit After Tax (QoQ) -141.47%681.47%-178.89%-11.13%118.82%
Property, Plant & Equipment (Net) Growth (1y) -31.37%31.01%
Property, Plant & Equipment (Net) Growth (3y) -87.54%-20.96%-9.22%
Property, Plant & Equipment (Net) Growth (5y) -70.84%
Property, Plant & Equipment (Net) (QoQ) -14.31%-3.57%70.73%-7.15%
Return on Assets Growth (1y) -53.00-24.00
Return on Assets (QoQ) -10.0048.00-57.00-34.0019.00
Return on Capital Employed (QoQ) -10.002.00
Return on Equity Growth (1y) -96.00-39.00
Return on Equity (QoQ) -14.0061.00-72.00-70.0043.00
Return on Invested Capital (QoQ) -15.003.00
Return on Sales Growth (1y) 210.00
Return on Sales (QoQ) 365.000.11M-0.11M20.00
Revenue Growth (3y) 61.84%
Revenue (QoQ) 2,163.42%-100.09%
Share-based Compensation Growth (1y) 316.21%424.00%
Share-based Compensation (QoQ) -28.62%3.15%583.24%-17.26%-10.13%
Shareholder's Equity Growth (1y) -45.65%-26.71%116.04%
Shareholder's Equity Growth (3y) 38.65%-32.10%-22.46%
Shareholder's Equity Growth (5y) 17.98%
Shareholder's Equity (QoQ) -19.46%89.10%-26.91%-34.17%137.41%
Tax Rate Growth (1y) -0.00M130.00
Tax Rate (QoQ) -0.00M-133.00245.00-138.00155.00